BEVERLY, Mass., Oct. 6, 2021 /PRNewswire/ -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) ("LexaGene" or the "Company"), a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system with results in approximately two hours, today announced Dr. Jack Regan, CEO and Founder, will present live at VirtualInvestorConferences.com on October 7th.
DATE: October 7th, 2021
TIME: 3:00 p.m. (ET)
LINK: https://bit.ly/2XDPsP9
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Recent Company Highlights
To learn more about LexaGene and the MiQLab System or subscribe to company updates, visit www.lexagene.com, or follow us on Twitter or LinkedIn.
https://www.prnewswire.com/news-releases/lexagene-to-webcast-live-at-virtualinvestorconferencescom-october-7th-301394103.html